The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Administration of a Novel Anti-NGF Monoclonal Antibody (AK115) in Healthy Participants: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase I Clinical Trial
新型抗NGF单克隆抗体（AK115）单次皮下注射在健康受试者中的安全性、耐受性、药代动力学和药效学：一项随机、双盲、安慰剂对照、剂量递增的I期临床试验
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S500902
Zhang, Juan; Fan, Yu-Xin; Huang, Yu; Guan, Runfang; Li, Ruixia; Long, Shuxian; Yang, Mei; Yu, Binge; Wang, Guo Qin; Chen, Peng; Gong, Xia; Li, Baiyong; Xia, Michelle; He, Jianchang
